Chinese SLE Treatment and Research Group (CSTAR) registry:VIII. Influence of socioeconomic and geographical variables on disease phenotype and activity in Chinese patients with SLE-Reference-Cited by-同舟云学术

Chinese SLE Treatment and Research Group (CSTAR) registry:VIII. Influence of socioeconomic and geographical variables on disease phenotype and activity in Chinese patients with SLE

Published:2017-03-13 Issue:3 Volume:21 Page:716-724
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Cheng Yongjing¹,Li Mengtao²,Zhao Jiuliang²,Ye Zhizhong³,Li Caifeng⁴,Li Xiaofeng⁵,Zhu Ping⁶,Wang Zhengang⁷,Zheng Yi⁸,Li Xiangpei⁹,Zhang Miaojia¹⁰,Huang Cibo¹,Zeng Xiaofeng²,

Affiliation:

1. Department of Rheumatology; National Center of Gerontology; Beijing Hospital; Beijing China

2. Department of Rheumatology; Peking Union Medical College Hospital; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education; Beijing China

3. Department of Rheumatology; The Fourth People's Hospital of Shenzhen Affiliated to Guangdong; Medical College; Guangdong China

4. Department of Rheumatology; Beijing Children's Hospital Affiliated to Capital Medical University; Beijing China

5. Department of Rheumatology; The Second Hospital of Shanxi Medical University; Shanxi China

6. Department of Clinical Immunology and Rheumatology; Xijing Hospital affiliated to the Fourth Military Medical University; Shanxi China

7. Department of Rheumatology; Beijing Tongren Hospital Affiliated to Capital Medical University; Beijing China

8. Department of Rheumatology; Beijing Chao-Yang Hospital Affiliated to Capital Medical University; Beijing China

9. Department of Rheumatology; Anhui Provincial Hospital; Anhui China

10. Department of Rheumatology; Jiangsu Provincial People's Hospital; Jiangsu China

Funder

Chinese National Key Technology R&D Program, Ministry of Science and Technology

Chinese National High Technology Research and Development Program, Ministry of Science and Technology

Research Special Fund for Public Welfare Industry of Health, Ministry of Health

National Major Scientific and Technological Special Project for “Significant New Drugs Development”, Ministry of Science and Technology

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1756-185X.13057/fullpdf

Reference40 articles.

1. Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences;Rua-Figueroa;Medicine (Baltimore),2015

2. Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary;Ugarte-Gil;Rheumatology (Oxford),2016

3. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture;Reveille;Arthritis Rheum,1998

4. Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA) XXXII: [corrected] contributions of admixture and socioeconomic status to renal involvement;Alarcon;Lupus,2006

5. Rare variants of ATG5 are likely to be associated with Chinese patients with systemic lupus erythematosus;Zhang;Medicine (Baltimore),2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients;Clinical Rheumatology;2024-07-04

2. Association of education attainment and risk of connective tissue diseases;International Journal of Rheumatic Diseases;2024-07

3. Epidemiology of SLE in Italy: an observational study using a primary care database;Lupus Science & Medicine;2024-05

4. Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial;Clinical Pharmacology & Therapeutics;2024-02-28

5. Systemic lupus erythematosus is associated with lower risk of hepatitis B virus infection: A multivariable Mendelian randomization study in East Asian population;Journal of Medical Virology;2023-11